Share on StockTwits

Chimera Investment Corp. (NYSE:CIM) was downgraded by Zacks to a “neutral” rating in a research report issued to clients and investors on Friday. They currently have a $3.30 price objective on the stock. Zacks‘s target price would suggest a potential upside of 2.17% from the stock’s previous close.

A number of other firms have also recently commented on CIM. Analysts at Keefe, Bruyette & Woods raised their price target on shares of Chimera Investment Corp. from $3.00 to $3.10 in a research note on Friday. They now have a “market perform” rating on the stock. Separately, analysts at Deutsche Bank reiterated a “hold” rating on shares of Chimera Investment Corp. in a research note on Thursday. They now have a $3.10 price target on the stock, up previously from $3.00. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of Chimera Investment Corp. in a research note on Thursday, July 24th. They now have a $3.25 price target on the stock, up previously from $3.00. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $3.19.

Chimera Investment Corp. (NYSE:CIM) traded up 0.31% during mid-day trading on Friday, hitting $3.24. 5,097,910 shares of the company’s stock traded hands. Chimera Investment Corp. has a 52 week low of $2.89 and a 52 week high of $3.34. The stock’s 50-day moving average is $3.18 and its 200-day moving average is $3.14. The company has a market cap of $3.329 billion and a P/E ratio of 9.79.

Chimera Investment Corp. (NYSE:CIM) last issued its quarterly earnings data on Monday, August 11th. The company reported $0.10 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.09 by $0.01. On average, analysts predict that Chimera Investment Corp. will post $0.38 earnings per share for the current fiscal year.

In other Chimera Investment Corp. news, CFO Robert S. Colligan bought 30,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, August 14th. The stock was purchased at an average cost of $3.21 per share, with a total value of $96,300.00. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.

Chimera Investment Corporation is a specialty finance company that invests, either directly or indirectly through its subsidiaries, in residential mortgage-backed securities (NYSE:CIM), residential mortgage loans, commercial mortgage loans, real estate-related securities and various other asset classes.

To view Zacks’ full report, visit Zacks’ official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.